Physician profile

Dennis M Chaney

Foot & Ankle Surgery · San Antonio, TX

NPI 1427107028

$15,547.09

in general payments reported to CMS, 2019-2025

48 companies · $2,582 in 2025

The $2,582 reported for 2025 was more than what 87% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).

See the full distribution for Foot & Ankle Surgery

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$6,231.09
Travel and Lodging$170.57

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Kerecis Limited $2,868.53 2019-2025 Kerecis Surgiclose, Kerecis Omega3 Marigen, Kerecis Graftguide
Stryker Corporation $2,571.87 2019-2025 Citrefix, Augment Injectable, Prophecy
Treace Medical Concepts, INC. $1,538.75 2021-2025
Medinc of Texas $1,245.60 2021-2023
Paratek Pharmaceuticals, INC. $1,215.16 2019-2025 Nuzyra
Smith+Nephew, INC. $1,046.32 2019-2025 Grafix Pl, Versajet, Regranex
Integra Lifesciences Corporation $698.87 2019-2025 Integra, Primatrix, Integra Dermal Regeneration Template
Organogenesis INC. $666.18 2019-2025 Affinity, Puraply, Simplimax
Melinta Therapeutics, LLC $565.65 2019-2025 Kimyrsa
Horizon Therapeutics Plc $380.48 2019-2023 Krystexxa
Paragon 28, INC. $370.15 2023 Apex 3d
Abbvie INC. $229.17 2021-2023 Dalvance
Ortho Dermatologics, A Division of Bausch Health US, LLC $191.71 2020-2025 Jublia
Acumed LLC $157.01 2021-2025 Osteomed, Acumed, Acumed
Kowa Pharmaceuticals America, INC. $148.38 2023 Seglentis
Show all 48 companies
CompanyGeneral paymentsYearsTop products
Orthofix Medical, INC. $144.31 2019-2025 Physio-Stim, Spinal-Stim
Medtronic, INC. $139.47 2022-2025 Inceptiv, Vanta Adaptivestim, Intellis Adaptivestim
Metric Medical Devices, INC. $128.75 2020-2025 Super Staple, Super Scaffold, Link External Fixator
Musculoskeletal Transplant Foundation INC. $124.68 2020
Averitas Pharma INC. $113.44 2023-2025 Qutenza
Sebela Pharmaceuticals INC. $94.50 2019-2020
Mission Medical Distribution, LLC $65.12 2023-2024
Grt US Holding, INC. $62.39 2021-2022
Amgen INC. $57.41 2024-2025 Krystexxa
Pacira Pharmaceuticals Incorporated $48.10 2024-2025 Exparel, Iovera
Fidia Pharma USA INC. $45.95 2020-2021
Axogen $43.77 2025
Medline Industries LP $42.83 2019-2023
Anika Therapeutics, INC. $42.73 2023 X-Twist, Tactoset, Ovomotion
Glenmark Therapeutics INC. $38.00 2019
Abbott Laboratories $37.71 2019-2023 Proclaim
Davol INC. $37.70 2023-2024 Arista Ah Flexitip
Kci USA, INC. $35.33 2020-2023 3m Cavilon, V.A.C. Dermatac, Activ.A.C.
Nevro Corp. $34.74 2022-2023 Senza
Linvatec Corporation $34.23 2025 Biobrace 23mm
Hydrofera LLC $33.21 2022-2024 Cutimed Sorbion
Triad Life Sciences INC. $31.78 2022
Vertex Pharmaceuticals Incorporated $29.42 2025
Nabriva Therapeutics, Plc $29.32 2021-2022
Aroa Biosurgery Incorporated $28.49 2025
Next Science LLC $21.30 2024 Surgx, Blastx, Xperience
Depuy Synthes Sales INC. $21.13 2023 Motoband
Medtronic Vascular, INC. $17.52 2019
Solventum Corporation $17.06 2024 V.A.C. Dermatac, Activ.A.C., Promogran Prisma
Hartmann USA, INC. $14.85 2025 Zetuvit Plus 10x10 P10
Acera Surgical, INC. $13.77 2019
Misonix INC $13.17 2019
Merck Sharp & Dohme LLC $11.08 2019

Drugs and devices associated with these payments

Nuzyra $1,002Kerecis Surgiclose $552Apex 3d $370Citrefix $316Augment Injectable $306Lapiplasty System 1 $301Lapiplasty System $252Kerecis Omega3 Marigen $188Grafix Pl $184Krystexxa $183Kimyrsa $179Integra $176Seglentis $148Kerecis Graftguide $138Physio-Stim $129Dalvance $129Qutenza $113Prophecy $112Anchorage $110Tmc Nanoplasty System $109N/A $108Tmc Speedmtp $99.84Affinity $97.73Jublia $86.41Puraply $82.53Asnis $73.41Acumed $60.75Integra Dermal Regeneration Template $58.75Primatrix $58.75Versajet $58.08Infinity Adaptis $57.23Inceptiv $54.77Prostep Mica $54.48Kerecis Omega3 Surgiclose $52.62Regranex $50.78Stravix $49.17Exparel $48.10Stravix Pl $47.61Collagenase Santyl $47.02Osteomed $46.26X-Twist $42.73Ovomotion $42.73Tactoset $42.73Activ.A.C. $40.74V.A.C. Dermatac $40.74Promogran Prisma $40.74Simplimax $39.56Super Scaffold $38.56Super Staple $38.56Via Matrix $38.02Arista Ah Flexitip $37.70Biobrace 23mm $34.23Iovera $33.15Novachor $31.75Medline Industries, INC. $31.33Grafix $29.47Journavx $29.42Puraply Wound Matrix $25.99Link External Fixator $25.41Easyfuse $24.69Nushield $24.663m Cavilon $23.68Kerecis Omega3 Graftguide $22.68Proclaim $21.37Xperience $21.30Blastx $21.30Surgx $21.30Motoband $21.13Link $20.00Cygnus Dual $19.99Senza $19.79Vanta Adaptivestim $18.55Apligraf $17.07Spinal-Stim $16.89Flexband $16.41Gravity $16.32Cutimed Sorbion $15.95Zetuvit Plus 10x10 P10 $14.85Intellis Adaptivestim $13.50T2 $13.37Renasys Go V2 Home $13.16Cadence $9.06Sonicanchor $4.81Prolayer $3.39Variax $2.71

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Dennis M Chaney

$15,547.09

in general payments reported 2019-2025

Years
2019-2025
Top company
Kerecis Limited
Context
The $2,582 reported for 2025 was more than what 87% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).

https://glasscript.com/doctor/64927/dennis-m-chaney

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.